title: Effect of intravitreal bevacizumab on macular and peripapillary choroidal thickness in injected and fellow eyes of patients with diabetic macular oedema.
authors: Department of Ophthalmology, Kırıkkale University School of Medicine, Kırıkkale, Turkey.
authors: Nurgül
authors: N
authors: Örnek
authors: Department of Ophthalmology, Kırıkkale University School of Medicine, Kırıkkale, Turkey.
authors: Kemal
authors: K
authors: Örnek
authors: Department of Ophthalmology, Kırıkkale University School of Medicine, Kırıkkale, Turkey.
authors: Tevfik
authors: T
authors: Oğurel
authors: Department of Ophthalmology, Kırıkkale University School of Medicine, Kırıkkale, Turkey.
authors: İnci Elif
authors: İE
authors: Timur
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D002829:Choroid / Q000473:pathology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009898:Optic Disk; D011446:Prospective Studies; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab